S5010 A Challenging Case of Gastric Bezoar in a Patient on Tirzepatide

Kristen Fadel, Evan Grossman, Laura Sahyoun(Cornell University), Ellen Scherl(NewYork–Presbyterian Hospital), Emily K. Smith, Michelle Lee, Eliza Cricco‐Lizza(Cornell University)

The American Journal of Gastroenterology

October 1, 2024

10.14309/01.ajg.0001049408.79846.f0

Cited by 2

Related Papers

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

|Gastroenterology|2008|750

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

|The Lancet|2022|301

Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation

|Nature|2022|214

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

|Gastroenterology|2022|84

Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans

|Gastroenterology|2015|82